Change Of Nominated Advisor and Corporate Broker

RNS Number : 9808G
Fevertree Drinks PLC
21 November 2022
 

21 November 2022

 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Change Of Nominated Advisor and Corporate Broker

Fever-Tree is pleased to announce the appointment of Investec Bank plc as the Company's Nominated Advisor in addition to its existing role as broker, as well as the appointment of Morgan Stanley & Co. International plc as corporate broker, both with immediate effect.

 

Ends

 

For further information:

 

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)7435 828 138

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I Alex Wright I +44 (0)20 7597 5970

 

Corporate Broker - Morgan Stanley & Co. International plc

Andrew Foster I Jessica Pauley I +44 (0)20 7425 8000

 

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan I +44 (0)7826 534 233

 

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPGPGWCGUPPGMB
UK 100

Latest directors dealings